Skip to main content
July 2, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
HER2
Bladder Cancer Treatment
Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer
By Dr. C.H. Weaver M.D.
Jun 13, 2022
Breast Cancer Overviews
Understanding Your Breast Pathology Reports
By Dr. C.H. Weaver M.D.
Jun 2, 2022
Uterine Cancer Treatment
Understand the role of NGS testing and Precision Cancer Medicines in the Management of Endometrial Cancer
By Dr. C.H. Weaver M.D.
Jun 2, 2022
Lung Cancer Treatment
Precision Cancer Medicines & Immunotherapy for Lung Cancer
By Dr. C.H. Weaver M.D.
May 29, 2022
Esophageal Cancer Overviews
Treatment of Stage IV of Esophageal Cancer
By CancerConnect
Jun 3, 2022
Breast Cancer Overviews
Precision Cancer Medicines and Breast Cancer
By Dr. C.H. Weaver M.D.
Feb 9, 2022
Breast Cancer Treatment
Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer
By Dr. C.H. Weaver M.D.
Oct 1, 2021
Bladder Cancer Overviews
Treatment of Stage IV Bladder Cancer
By Dr. C.H. Weaver M.D.
Aug 11, 2021
Breast Cancer Treatment
Kadcyla (T-DM1) Significantly Improves Treatment of HER 2 + Breast Cancers
By Dr. C.H. Weaver M.D.
Oct 6, 2021
Gastric Cancer Overviews
Treatment for Stage IV Gastric Cancer
By Dr. C.H. Weaver M.D.
Jun 9, 2021
Breast Cancer Treatment
Herceptin® Improves Cancer-Free Survival in HER2 + positive Early Breast Cancer
By Dr. C.H. Weaver M.D.
Feb 23, 2022
Gastric Cancer Overviews
Treatment & Management of Gastric Cancer
By Dr. C.H. Weaver M.D.
Jun 29, 2022
Uterine Cancer Treatment
Targeting HER2 in Uterine Cancer
By Dr. C.H. Weaver M.D.
Jun 29, 2021
CLOSE
CLOSE
CLOSE
CLOSE